Pancreatogenic diabetes, acute pancreatitis management, and pancreatic tuberculosis: Appraising the present and setting goals for the future

Most developed countries in the world have experienced an epidemiologic transition, in which life expectancy has increased, and chronic diseases have replaced infections as the leading cause of death.1 In the field of pancreatology, this has translated into increased clinical and research efforts to decrease the burden, morbidity, and mortality associated with benign inflammatory disorders and pancreatic cancer. As a result, there has been a...